Back to calendar
Lineage Cell Therapeutics, Inc. (LCTX) Earnings
LCTX reports earnings on Thursday, August 6, 2026
earnings report
August 6, 2026 · After Market Close
Q2 2026
Est. EPS: $-0.03
Actual EPS: $-0.03
EPS surprise: -5.88%
Company overview
Market Cap$280.7M
PriceUSD 1.11
EPS (TTM)-0.18
52-week high2.09
52-week low1.00
SectorHealth Technology
IndustryBiotechnology
Employees77